HEADER HYDROLASE 17-AUG-17 5QC8 TITLE CRYSTAL STRUCTURE OF HUMAN CATHEPSIN-S WITH BOUND LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHEPSIN S; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.22.27; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CTSS; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS D3R, CATHEPSIN S, LIGAND DOCKING, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.D.BEMBENEK,M.K.AMERIKS,T.MIRZADEGAN,H.YANG,C.SHAO,S.K.BURLEY REVDAT 6 23-OCT-24 5QC8 1 REMARK REVDAT 5 17-NOV-21 5QC8 1 REMARK REVDAT 4 10-FEB-21 5QC8 1 AUTHOR JRNL REVDAT 3 06-JUN-18 5QC8 1 REMARK SITE SCALE ATOM REVDAT 2 21-FEB-18 5QC8 1 REMARK REVDAT 1 20-DEC-17 5QC8 0 JRNL AUTH S.D.BEMBENEK,M.K.AMERIKS,T.MIRZADEGAN,H.YANG,C.SHAO, JRNL AUTH 2 S.K.BURLEY JRNL TITL CRYSTAL STRUCTURE OF HUMAN CATHEPSIN-S WITH BOUND LIGAND JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.74 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.74 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.46 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 91.8 REMARK 3 NUMBER OF REFLECTIONS : 38560 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.198 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2039 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.74 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.79 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2288 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 73.94 REMARK 3 BIN R VALUE (WORKING SET) : 0.2370 REMARK 3 BIN FREE R VALUE SET COUNT : 112 REMARK 3 BIN FREE R VALUE : 0.2580 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3395 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 92 REMARK 3 SOLVENT ATOMS : 553 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.25000 REMARK 3 B22 (A**2) : -0.09000 REMARK 3 B33 (A**2) : -0.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.09000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.129 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.117 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.078 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.425 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3585 ; 0.012 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3119 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4860 ; 1.407 ; 1.923 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7259 ; 0.935 ; 2.988 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 440 ; 5.652 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 161 ;37.676 ;24.472 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 547 ;11.776 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;15.021 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 484 ; 0.086 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4052 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 760 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1766 ; 0.878 ; 1.155 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1765 ; 0.875 ; 1.154 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2204 ; 1.378 ; 1.727 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2205 ; 1.378 ; 1.727 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1819 ; 1.633 ; 1.409 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1820 ; 1.633 ; 1.408 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2657 ; 2.611 ; 2.027 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4334 ; 4.883 ;15.336 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4153 ; 4.432 ;14.257 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 0 220 B 0 220 14498 0.07 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5QC8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-AUG-17. REMARK 100 THE DEPOSITION ID IS D_1001401765. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-MAY-06 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38560 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.740 REMARK 200 RESOLUTION RANGE LOW (A) : 45.460 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM SODIUM ACETATE PH 4.5, 200MM REMARK 280 AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K, PH 4.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 45.53100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 18.57650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 45.53100 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 18.57650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1186 LIES ON A SPECIAL POSITION. REMARK 375 HOH B1224 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 221 REMARK 465 GLY A 222 REMARK 465 GLY B 221 REMARK 465 GLY B 222 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 0 CG1 CG2 CD1 REMARK 470 LYS A 60 CD CE NZ REMARK 470 LYS A 82 CE NZ REMARK 470 LYS A 98 CG CD CE NZ REMARK 470 ILE B 0 CG1 CG2 CD1 REMARK 470 LYS B 60 CD CE NZ REMARK 470 LYS B 82 CE NZ REMARK 470 LYS B 98 CG CD CE NZ REMARK 470 TRP B 186 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 186 CZ3 CH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 1250 O HOH A 1250 2554 1.37 REMARK 500 O HOH A 1203 O HOH A 1203 2554 1.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 58 -129.04 -114.34 REMARK 500 ASN A 163 11.04 -151.05 REMARK 500 THR B 58 -130.73 -113.17 REMARK 500 ASN B 163 11.77 -149.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B1271 DISTANCE = 6.43 ANGSTROMS REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 BFV A 901 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BFV A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BFV B 901 DBREF 5QC8 A 0 217 UNP P25774 CATS_HUMAN 114 331 DBREF 5QC8 B 0 217 UNP P25774 CATS_HUMAN 114 331 SEQADV 5QC8 SER A 25 UNP P25774 CYS 139 ENGINEERED MUTATION SEQADV 5QC8 LEU A 218 UNP P25774 EXPRESSION TAG SEQADV 5QC8 GLN A 219 UNP P25774 EXPRESSION TAG SEQADV 5QC8 GLY A 220 UNP P25774 EXPRESSION TAG SEQADV 5QC8 GLY A 221 UNP P25774 EXPRESSION TAG SEQADV 5QC8 GLY A 222 UNP P25774 EXPRESSION TAG SEQADV 5QC8 SER B 25 UNP P25774 CYS 139 ENGINEERED MUTATION SEQADV 5QC8 LEU B 218 UNP P25774 EXPRESSION TAG SEQADV 5QC8 GLN B 219 UNP P25774 EXPRESSION TAG SEQADV 5QC8 GLY B 220 UNP P25774 EXPRESSION TAG SEQADV 5QC8 GLY B 221 UNP P25774 EXPRESSION TAG SEQADV 5QC8 GLY B 222 UNP P25774 EXPRESSION TAG SEQRES 1 A 223 ILE LEU PRO ASP SER VAL ASP TRP ARG GLU LYS GLY CYS SEQRES 2 A 223 VAL THR GLU VAL LYS TYR GLN GLY SER CYS GLY ALA SER SEQRES 3 A 223 TRP ALA PHE SER ALA VAL GLY ALA LEU GLU ALA GLN LEU SEQRES 4 A 223 LYS LEU LYS THR GLY LYS LEU VAL SER LEU SER ALA GLN SEQRES 5 A 223 ASN LEU VAL ASP CYS SER THR GLU LYS TYR GLY ASN LYS SEQRES 6 A 223 GLY CYS ASN GLY GLY PHE MET THR THR ALA PHE GLN TYR SEQRES 7 A 223 ILE ILE ASP ASN LYS GLY ILE ASP SER ASP ALA SER TYR SEQRES 8 A 223 PRO TYR LYS ALA MET ASP GLN LYS CYS GLN TYR ASP SER SEQRES 9 A 223 LYS TYR ARG ALA ALA THR CYS SER LYS TYR THR GLU LEU SEQRES 10 A 223 PRO TYR GLY ARG GLU ASP VAL LEU LYS GLU ALA VAL ALA SEQRES 11 A 223 ASN LYS GLY PRO VAL SER VAL GLY VAL ASP ALA ARG HIS SEQRES 12 A 223 PRO SER PHE PHE LEU TYR ARG SER GLY VAL TYR TYR GLU SEQRES 13 A 223 PRO SER CYS THR GLN ASN VAL ASN HIS GLY VAL LEU VAL SEQRES 14 A 223 VAL GLY TYR GLY ASP LEU ASN GLY LYS GLU TYR TRP LEU SEQRES 15 A 223 VAL LYS ASN SER TRP GLY HIS ASN PHE GLY GLU GLU GLY SEQRES 16 A 223 TYR ILE ARG MET ALA ARG ASN LYS GLY ASN HIS CYS GLY SEQRES 17 A 223 ILE ALA SER PHE PRO SER TYR PRO GLU ILE LEU GLN GLY SEQRES 18 A 223 GLY GLY SEQRES 1 B 223 ILE LEU PRO ASP SER VAL ASP TRP ARG GLU LYS GLY CYS SEQRES 2 B 223 VAL THR GLU VAL LYS TYR GLN GLY SER CYS GLY ALA SER SEQRES 3 B 223 TRP ALA PHE SER ALA VAL GLY ALA LEU GLU ALA GLN LEU SEQRES 4 B 223 LYS LEU LYS THR GLY LYS LEU VAL SER LEU SER ALA GLN SEQRES 5 B 223 ASN LEU VAL ASP CYS SER THR GLU LYS TYR GLY ASN LYS SEQRES 6 B 223 GLY CYS ASN GLY GLY PHE MET THR THR ALA PHE GLN TYR SEQRES 7 B 223 ILE ILE ASP ASN LYS GLY ILE ASP SER ASP ALA SER TYR SEQRES 8 B 223 PRO TYR LYS ALA MET ASP GLN LYS CYS GLN TYR ASP SER SEQRES 9 B 223 LYS TYR ARG ALA ALA THR CYS SER LYS TYR THR GLU LEU SEQRES 10 B 223 PRO TYR GLY ARG GLU ASP VAL LEU LYS GLU ALA VAL ALA SEQRES 11 B 223 ASN LYS GLY PRO VAL SER VAL GLY VAL ASP ALA ARG HIS SEQRES 12 B 223 PRO SER PHE PHE LEU TYR ARG SER GLY VAL TYR TYR GLU SEQRES 13 B 223 PRO SER CYS THR GLN ASN VAL ASN HIS GLY VAL LEU VAL SEQRES 14 B 223 VAL GLY TYR GLY ASP LEU ASN GLY LYS GLU TYR TRP LEU SEQRES 15 B 223 VAL LYS ASN SER TRP GLY HIS ASN PHE GLY GLU GLU GLY SEQRES 16 B 223 TYR ILE ARG MET ALA ARG ASN LYS GLY ASN HIS CYS GLY SEQRES 17 B 223 ILE ALA SER PHE PRO SER TYR PRO GLU ILE LEU GLN GLY SEQRES 18 B 223 GLY GLY HET BFV A 901 46 HET BFV B 901 46 HETNAM BFV N-BENZYL-1-{3-[(2-CHLORO-5-{5-(METHYLSULFONYL)-1-[3- HETNAM 2 BFV (MORPHOLIN-4-YL)PROPYL]-4,5,6,7-TETRAHYDRO-1H- HETNAM 3 BFV PYRAZOLO[4,3-C]PYRIDIN-3-YL}PHENYL) HETNAM 4 BFV ETHYNYL]PHENYL}METHANAMINE FORMUL 3 BFV 2(C36 H40 CL N5 O3 S) FORMUL 5 HOH *553(H2 O) HELIX 1 AA1 ARG A 8 GLY A 11 5 4 HELIX 2 AA2 ALA A 24 GLY A 43 1 20 HELIX 3 AA3 SER A 49 SER A 57 1 9 HELIX 4 AA4 THR A 58 GLY A 62 5 5 HELIX 5 AA5 LYS A 64 GLY A 68 5 5 HELIX 6 AA6 PHE A 70 LYS A 82 1 13 HELIX 7 AA7 ASP A 102 LYS A 104 5 3 HELIX 8 AA8 ARG A 120 LYS A 131 1 12 HELIX 9 AA9 HIS A 142 LEU A 147 1 6 HELIX 10 AB1 ASN A 204 ILE A 208 5 5 HELIX 11 AB2 ARG B 8 GLY B 11 5 4 HELIX 12 AB3 ALA B 24 GLY B 43 1 20 HELIX 13 AB4 SER B 49 SER B 57 1 9 HELIX 14 AB5 THR B 58 GLY B 62 5 5 HELIX 15 AB6 LYS B 64 GLY B 68 5 5 HELIX 16 AB7 PHE B 70 LYS B 82 1 13 HELIX 17 AB8 ASP B 102 LYS B 104 5 3 HELIX 18 AB9 ARG B 120 LYS B 131 1 12 HELIX 19 AC1 HIS B 142 LEU B 147 1 6 HELIX 20 AC2 ASN B 204 ILE B 208 5 5 SHEET 1 AA1 3 VAL A 5 ASP A 6 0 SHEET 2 AA1 3 GLY A 165 LEU A 174 -1 O TYR A 171 N VAL A 5 SHEET 3 AA1 3 VAL A 134 GLY A 137 -1 N VAL A 134 O VAL A 168 SHEET 1 AA2 5 VAL A 5 ASP A 6 0 SHEET 2 AA2 5 GLY A 165 LEU A 174 -1 O TYR A 171 N VAL A 5 SHEET 3 AA2 5 LYS A 177 LYS A 183 -1 O LYS A 183 N LEU A 167 SHEET 4 AA2 5 TYR A 195 ALA A 199 -1 O MET A 198 N TRP A 180 SHEET 5 AA2 5 VAL A 152 TYR A 153 1 N TYR A 153 O ARG A 197 SHEET 1 AA3 2 ILE A 84 ASP A 85 0 SHEET 2 AA3 2 ARG A 106 ALA A 108 -1 O ALA A 107 N ILE A 84 SHEET 1 AA4 2 LYS A 112 GLU A 115 0 SHEET 2 AA4 2 SER A 213 GLU A 216 -1 O GLU A 216 N LYS A 112 SHEET 1 AA5 3 VAL B 5 ASP B 6 0 SHEET 2 AA5 3 GLY B 165 LEU B 174 -1 O TYR B 171 N VAL B 5 SHEET 3 AA5 3 VAL B 134 GLY B 137 -1 N VAL B 134 O VAL B 168 SHEET 1 AA6 5 VAL B 5 ASP B 6 0 SHEET 2 AA6 5 GLY B 165 LEU B 174 -1 O TYR B 171 N VAL B 5 SHEET 3 AA6 5 LYS B 177 LYS B 183 -1 O LYS B 183 N LEU B 167 SHEET 4 AA6 5 TYR B 195 ALA B 199 -1 O MET B 198 N TRP B 180 SHEET 5 AA6 5 VAL B 152 TYR B 153 1 N TYR B 153 O ARG B 197 SHEET 1 AA7 2 ILE B 84 ASP B 85 0 SHEET 2 AA7 2 ARG B 106 ALA B 108 -1 O ALA B 107 N ILE B 84 SHEET 1 AA8 2 LYS B 112 GLU B 115 0 SHEET 2 AA8 2 SER B 213 GLU B 216 -1 O GLU B 216 N LYS B 112 SSBOND 1 CYS A 22 CYS A 66 1555 1555 2.05 SSBOND 2 CYS A 56 CYS A 99 1555 1555 2.10 SSBOND 3 CYS A 158 CYS A 206 1555 1555 2.05 SSBOND 4 CYS B 22 CYS B 66 1555 1555 2.06 SSBOND 5 CYS B 56 CYS B 99 1555 1555 2.10 SSBOND 6 CYS B 158 CYS B 206 1555 1555 2.02 SITE 1 AC1 17 GLY A 23 ASN A 67 GLY A 68 PHE A 70 SITE 2 AC1 17 MET A 71 TYR A 118 GLY A 137 ASN A 161 SITE 3 AC1 17 VAL A 162 ASN A 163 HIS A 164 GLY A 165 SITE 4 AC1 17 PHE A 211 GLN A 219 HOH A1004 HOH A1127 SITE 5 AC1 17 HOH A1186 SITE 1 AC2 20 GLY B 23 ASN B 67 GLY B 68 GLY B 69 SITE 2 AC2 20 PHE B 70 MET B 71 THR B 73 TYR B 118 SITE 3 AC2 20 GLY B 137 ASN B 161 VAL B 162 ASN B 163 SITE 4 AC2 20 HIS B 164 GLY B 165 PHE B 211 GLN B 219 SITE 5 AC2 20 HOH B1044 HOH B1105 HOH B1159 HOH B1196 CRYST1 91.062 37.153 127.677 90.00 93.14 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010982 0.000000 0.000603 0.00000 SCALE2 0.000000 0.026916 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007844 0.00000